o Name of the product, active substance and approved indication of the producto Relevant information on the safety concern “Gastroinstestinal toxicity (diarrhea)” (e.g. seriousness, severity, frequency, time to onset, duration, reversibility of the AE as applicable)o Details of the population at higher risk for the safety concerno Key message to convey in patients counselling on how to prevent and minimise Gastrointestinal toxicity through appropriate monitoring and management: